Apria Inc is a medical instruments & supplies business based in the US. Apria shares (APR) are listed on the NASDAQ and all prices are listed in US Dollars. Apria employs 6,120 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Apria
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – APR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Apria stock price (NASDAQ: APR)Use our graph to track the performance of APR stocks over time.
Apria shares at a glance
|Latest market close||$35.10|
|52-week range||$20.07 - $38.47|
|50-day moving average||$35.56|
|200-day moving average||$31.50|
|Wall St. target price||$34.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$2.83|
Buy Apria shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Apria stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Apria price performance over time
|1 week (2021-10-15)||2.72%|
|1 month (2021-09-24)||-1.10%|
|3 months (2021-07-23)||25.45%|
|6 months (2021-04-23)||17.31%|
|1 year (2020-10-20)||N/A|
|2 years (2019-10-20)||N/A|
|3 years (2018-10-20)||N/A|
|5 years (2016-10-20)||N/A|
Is Apria under- or over-valued?
Valuing Apria stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Apria's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Apria's P/E ratio
Apria's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, Apria shares trade at around 12x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Apria's P/E ratio is best considered in relation to those of others within the medical instruments & supplies industry or those of similar companies.
Apria's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $233.3 million.
The EBITDA is a measure of a Apria's overall financial performance and is widely used to measure a its profitability.
To put Apria's EBITDA into context you can compare it against that of similar companies.
|Revenue TTM||$1.1 billion|
|Operating margin TTM||10.35%|
|Gross profit TTM||$881.8 million|
|Return on assets TTM||11.11%|
|Return on equity TTM||74.74%|
|Market capitalisation||$1.2 billion|
TTM: trailing 12 months
Shorting Apria shares
There are currently 1.3 million Apria shares held short by investors – that's known as Apria's "short interest". This figure is 106.8% up from 620,142 last month.
There are a few different ways that this level of interest in shorting Apria shares can be evaluated.
Apria's "short interest ratio" (SIR)
Apria's "short interest ratio" (SIR) is the quantity of Apria shares currently shorted divided by the average quantity of Apria shares traded daily (recently around 442233.79310345). Apria's SIR currently stands at 2.9. In other words for every 100,000 Apria shares traded daily on the market, roughly 2900 shares are currently held short.
To gain some more context, you can compare Apria's short interest ratio against those of similar companies.
However Apria's short interest can also be evaluated against the total number of Apria shares, or, against the total number of tradable Apria shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Apria's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Apria shares in existence, roughly 40 shares are currently held short) or 0.1161% of the tradable shares (for every 100,000 tradable Apria shares, roughly 116 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Apria.
Find out more about how you can short Apria stock.
Apria share dividends
We're not expecting Apria to pay a dividend over the next 12 months.
You may also wish to consider:
- National HealthCare Corporation (NHC.US) (2.95% forward annual dividend yield)
- The Ensign Group (ENSG.US) (0.28% forward annual dividend yield)
Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. The company was incorporated in 2018 and is headquartered in Indianapolis, Indiana. .
Apria in the news
Apria Reaches Analyst Target Price
Chief Accounting Officer Of Apria Trades $260K In Company Stock
Apria to Announce Third Quarter 2021 Financial Results
Frequently asked questionsWhat percentage of Apria is owned by insiders or institutions?
Currently 2.892% of Apria shares are held by insiders and 100.012% by institutions. How many people work for Apria?
Latest data suggests 6,120 work at Apria. When does the fiscal year end for Apria?
Apria's fiscal year ends in December. Where is Apria based?
Apria's address is: 7353 Company Drive, Indianapolis, IN, United States, 46237 What is Apria's ISIN number?
Apria's international securities identification number is: US03836A1016
More guides on Finder
How to buy ProShares Bitcoin Strategy ETF (BITO)
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
How to buy The Real Good Food Company (RGF) stock when it goes public
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
How to buy Lulu’s Fashion Lounge Holdings (LVLU) stock when it goes public
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
How to buy Allarity Therapeutics (ALLR) stock when it goes public
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
How to buy Jupiter Neurosciences (JUNS) stock when it goes public
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
How to buy Mainz Biomed (MYNZ) stock when it goes public
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
How to buy Progressive Care stock when it goes public
Everything we know about the Progressive Care IPO, plus information on how to buy in.
How to buy Desert Peak Minerals (DPM) stock when it goes public
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
How to buy Vaxxinity (VAXX) stock when it goes public
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
How to buy Entrada Therapeutics (TRDA) stock when it goes public
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
Ask an Expert